51. Functions of purified gB, gE:gI, and gH:gL, and their sialyl residues in varicella-zoster virus infection
- Author
-
K Shiraki, Z. H. Li, T. Yokoyama, Jun-ichi Yamamura, Masahiko Kurokawa, T. Hasegawa, T. Okuno, Seiji Kageyama, and Hitoshi Sato
- Subjects
Viral Plaque Assay ,Herpesvirus 3, Human ,medicine.drug_class ,viruses ,Guinea Pigs ,Neuraminidase ,Monoclonal antibody ,medicine.disease_cause ,Herpesviridae ,Virus ,Cell Line ,Microbiology ,Mice ,Viral Proteins ,chemistry.chemical_compound ,Viral Envelope Proteins ,Virology ,medicine ,Animals ,Humans ,chemistry.chemical_classification ,Membrane Glycoproteins ,biology ,Varicella zoster virus ,General Medicine ,N-Acetylneuraminic Acid ,Sialic acid ,chemistry ,biology.protein ,Glycoprotein - Abstract
Varicella-zoster virus glycoproteins were purified by using monoclonal antibodies and analyzed for their effects on cell-free virus infection. Preinfection treatment of cells with gH:gL reduced the infection efficiency and increased the number of unadsorbed virus. Postinfection treatment of cells with gB increased the infection efficiency, but that with gE:gI reduced it. Treatment of gE:gI and gH:gL with neuraminidase (NA) abolished their inhibitory activity and the plaque formation was enhanced by NA treatment of glycoproteins and cells. Glycoproteins exhibited their diverse activities despite their common role in viral penetration, and sialyl residues were responsible for their function in cell-free virus infection.
- Published
- 1997
- Full Text
- View/download PDF